FENC logo

Fennec Pharmaceuticals Inc

FENC

$9.74

- $0.03 (-0.31%) This month

Closed: 4 Mar 2024 21:00 US/Eastern

Key details

CEO

Rostislav Raykov

Employees

30

Headquarters

Durham, US

Sector

Manufacturing

Industry

Biological Product (except Diagnostic) Manufacturing

About Fennec Pharmaceuticals Inc

fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG